| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 COMP MATN4 SVEP1 RYR1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 ATP2C1 SCUBE2 LOXL2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 2.40e-09 | 749 | 96 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.48e-06 | 188 | 96 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 4.07e-06 | 192 | 96 | 8 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.79e-06 | 268 | 96 | 9 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.56e-05 | 323 | 96 | 9 | GO:1901681 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 2.27e-04 | 5 | 96 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | Notch binding | 2.90e-04 | 27 | 96 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 6.29e-04 | 8 | 96 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.00e-03 | 10 | 96 | 2 | GO:0140947 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PAPPA2 DGCR2 COMP ASH1L MECOM LAMC1 LAMC2 SIX4 MFRP RYR1 JAG2 SLIT2 THBS3 LIMS1 NTNG2 SCUBE2 JAG1 LRP2 NOTCH1 NOTCH2 | 1.50e-06 | 1269 | 97 | 20 | GO:0009887 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.10e-06 | 20 | 97 | 4 | GO:0003184 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 4.54e-06 | 24 | 97 | 4 | GO:0003177 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | UPB1 MBNL1 MECOM GRN SIX4 MFRP ADAM10 JAG2 SLIT2 LIMS1 LRP2 POLR1B ZBTB18 NOTCH1 NOTCH2 | 2.78e-05 | 929 | 97 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | heterochromatin organization | 2.79e-05 | 13 | 97 | 3 | GO:0070828 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | LAMC1 LAMC2 ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 MUC3A NOTCH1 NOTCH2 EPHA4 NCKAP1L | 3.12e-05 | 826 | 97 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | cardiac septum development | 4.09e-05 | 134 | 97 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | axon guidance | 6.01e-05 | 285 | 97 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.16e-05 | 286 | 97 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 6.30e-05 | 89 | 97 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 6.55e-05 | 3 | 97 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | UPB1 MBNL1 MECOM GRN SIX4 ADAM10 JAG2 SLIT2 LIMS1 LRP2 POLR1B ZBTB18 NOTCH1 NOTCH2 | 8.46e-05 | 906 | 97 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | renal system development | 8.60e-05 | 386 | 97 | 9 | GO:0072001 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 8.97e-05 | 50 | 97 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | LAMC1 LAMC2 ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 NOTCH1 NOTCH2 EPHA4 NCKAP1L | 9.63e-05 | 802 | 97 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 1.08e-04 | 20 | 97 | 3 | GO:0042492 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 1.17e-04 | 162 | 97 | 6 | GO:0072073 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | LAMC1 LAMC2 ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 NOTCH1 NOTCH2 EPHA4 NCKAP1L | 1.19e-04 | 819 | 97 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | muscle structure development | COMP CACNA2D2 MBNL1 LAMC1 SIX4 ADAM12 RYR1 JAG1 LRP2 FHL3 ZBTB18 NOTCH1 NOTCH2 | 1.88e-04 | 858 | 97 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | inner ear development | 1.93e-04 | 253 | 97 | 7 | GO:0048839 | |
| GeneOntologyBiologicalProcess | axon development | LAMC1 LAMC2 GRN SLIT2 NELL2 NTNG2 PLXNC1 LRP2 NOTCH1 NOTCH2 EPHA4 | 2.14e-04 | 642 | 97 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 2.17e-04 | 5 | 97 | 2 | GO:0018057 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.21e-04 | 63 | 97 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 3.24e-04 | 6 | 97 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 3.24e-04 | 6 | 97 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.24e-04 | 6 | 97 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 3.24e-04 | 6 | 97 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 3.24e-04 | 6 | 97 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | axonogenesis | LAMC1 LAMC2 SLIT2 NELL2 NTNG2 PLXNC1 LRP2 NOTCH1 NOTCH2 EPHA4 | 3.31e-04 | 566 | 97 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | kidney development | 3.71e-04 | 372 | 97 | 8 | GO:0001822 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition | 3.97e-04 | 203 | 97 | 6 | GO:0001837 | |
| GeneOntologyBiologicalProcess | ear development | 3.98e-04 | 285 | 97 | 7 | GO:0043583 | |
| GeneOntologyBiologicalProcess | chondrocyte proliferation | 4.12e-04 | 31 | 97 | 3 | GO:0035988 | |
| GeneOntologyBiologicalProcess | artery development | 4.14e-04 | 133 | 97 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | neuron development | LAMC1 LAMC2 GRN MFRP ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 ZBTB18 ALK NOTCH1 NOTCH2 EPHA4 NCKAP1L | 4.40e-04 | 1463 | 97 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CASP9 LAMC1 LAMC2 ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 MUC3A NOTCH1 NOTCH2 EPHA4 NCKAP1L | 4.44e-04 | 1194 | 97 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of aspartic-type peptidase activity | 4.53e-04 | 7 | 97 | 2 | GO:1905247 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 4.96e-04 | 596 | 97 | 10 | GO:0001701 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 4.97e-04 | 33 | 97 | 3 | GO:0046629 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.99e-04 | 212 | 97 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | heart valve development | 5.02e-04 | 78 | 97 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 5.02e-04 | 78 | 97 | 4 | GO:0035315 | |
| GeneOntologyBiologicalProcess | aorta development | 5.53e-04 | 80 | 97 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | vasculature development | STAB2 COMP GRN ADAM12 ADAM10 SVEP1 SLIT2 LOXL2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 6.02e-04 | 969 | 97 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRE CACNA2D2 LAMC1 GRN SIX4 ADAM10 SVEP1 SLIT2 LIMS1 NTNG2 PLXNC1 ST8SIA2 EPHA4 | 6.31e-04 | 974 | 97 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | skeletal system development | 6.32e-04 | 615 | 97 | 10 | GO:0001501 | |
| GeneOntologyBiologicalProcess | limb development | 6.66e-04 | 224 | 97 | 6 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 6.66e-04 | 224 | 97 | 6 | GO:0048736 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 7.71e-04 | 9 | 97 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 7.71e-04 | 9 | 97 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | regulation of aspartic-type peptidase activity | 7.71e-04 | 9 | 97 | 2 | GO:1905245 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | LAMC1 LAMC2 ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 LRP2 NOTCH1 NOTCH2 EPHA4 | 7.74e-04 | 748 | 97 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 8.15e-04 | 39 | 97 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | MECOM LAMC1 SLIT2 NELL1 SCUBE2 PLXNC1 LOXL2 JAG1 LRP2 AKAP11 NOTCH1 NOTCH2 EPHA4 NCKAP1L | 8.81e-04 | 1141 | 97 | 14 | GO:0045597 |
| GeneOntologyBiologicalProcess | ventricular septum development | 8.98e-04 | 91 | 97 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 9.36e-04 | 92 | 97 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | neuron projection development | LAMC1 LAMC2 GRN ADAM10 SLIT2 NELL2 NTNG2 PLXNC1 ST8SIA2 LRP2 ALK NOTCH1 NOTCH2 EPHA4 NCKAP1L | 9.47e-04 | 1285 | 97 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 9.61e-04 | 10 | 97 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | corticospinal tract morphogenesis | 9.61e-04 | 10 | 97 | 2 | GO:0021957 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 9.61e-04 | 10 | 97 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte proliferation | 9.61e-04 | 10 | 97 | 2 | GO:1902732 | |
| GeneOntologyBiologicalProcess | podocyte development | 9.61e-04 | 10 | 97 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | distal tubule development | 9.61e-04 | 10 | 97 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 9.61e-04 | 10 | 97 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 9.85e-04 | 161 | 97 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 9.85e-04 | 161 | 97 | 5 | GO:0003231 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 1.01e-03 | 94 | 97 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | embryo development | UPB1 MBNL1 MECOM GRN SIX4 MFRP ADAM10 JAG2 SLIT2 LIMS1 JAG1 LRP2 POLR1B ZBTB18 NOTCH1 NOTCH2 | 1.04e-03 | 1437 | 97 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of synapse pruning | 1.17e-03 | 11 | 97 | 2 | GO:1905806 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 1.24e-03 | 45 | 97 | 3 | GO:0030866 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.32e-03 | 46 | 97 | 3 | GO:0003176 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 COMP LAMC1 LAMC2 CFP MATN4 MUC5B ADAM10 SVEP1 SLIT2 THBS3 LOXL2 LOXL4 LTBP1 | 1.98e-06 | 656 | 97 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 COMP LAMC1 LAMC2 CFP MATN4 MUC5B ADAM10 SVEP1 SLIT2 THBS3 LOXL2 LOXL4 LTBP1 | 2.05e-06 | 658 | 97 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 COMP LAMC1 LAMC2 CFP MATN4 ADAM10 SLIT2 THBS3 LOXL2 LOXL4 LTBP1 | 6.28e-06 | 530 | 97 | 12 | GO:0062023 |
| Domain | EGF-like_CS | LAMB4 MUC3B STAB2 COMP LAMC1 LAMC2 MATN4 ADAM12 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 2.87e-22 | 261 | 96 | 23 | IPR013032 |
| Domain | EGF_2 | LAMB4 MUC3B STAB2 COMP LAMC1 LAMC2 MATN4 ADAM12 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 4.07e-22 | 265 | 96 | 23 | PS01186 |
| Domain | EGF-like_dom | MUC3B STAB2 COMP LAMC1 LAMC2 MATN4 ADAM12 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 2.44e-21 | 249 | 96 | 22 | IPR000742 |
| Domain | EGF_1 | LAMB4 MUC3B STAB2 COMP LAMC1 LAMC2 MATN4 ADAM12 SVEP1 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 4.12e-21 | 255 | 96 | 22 | PS00022 |
| Domain | EGF | MUC3B STAB2 COMP LAMC1 LAMC2 MATN4 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 1.72e-20 | 235 | 96 | 21 | SM00181 |
| Domain | EGF_3 | MUC3B STAB2 COMP MATN4 ADAM12 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 MUC3A NOTCH1 NOTCH2 | 4.06e-19 | 235 | 96 | 20 | PS50026 |
| Domain | EGF_CA | STAB2 COMP MATN4 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 1.70e-18 | 122 | 96 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | STAB2 COMP MATN4 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 2.23e-18 | 124 | 96 | 16 | IPR001881 |
| Domain | Growth_fac_rcpt_ | STAB2 COMP LAMC1 LAMC2 RSPO4 MATN4 SVEP1 JAG2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 3.41e-18 | 156 | 96 | 17 | IPR009030 |
| Domain | EGF_CA | COMP MATN4 SVEP1 ADGRL4 JAG2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 1.13e-17 | 86 | 96 | 14 | PF07645 |
| Domain | EGF_Ca-bd_CS | COMP SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 6.63e-17 | 97 | 96 | 14 | IPR018097 |
| Domain | EGF_CA | COMP SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 THBS3 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 8.93e-17 | 99 | 96 | 14 | PS01187 |
| Domain | ASX_HYDROXYL | MATN4 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 3.72e-15 | 100 | 96 | 13 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | MATN4 SVEP1 ADGRL4 JAG2 SLIT2 NELL1 NELL2 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 8.12e-15 | 106 | 96 | 13 | IPR000152 |
| Domain | EGF_extracell | 4.86e-13 | 60 | 96 | 10 | IPR013111 | |
| Domain | EGF_2 | 4.86e-13 | 60 | 96 | 10 | PF07974 | |
| Domain | EGF | STAB2 MATN4 SVEP1 JAG2 SLIT2 NTNG2 SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 | 2.02e-12 | 126 | 96 | 12 | PF00008 |
| Domain | hEGF | 5.41e-09 | 28 | 96 | 6 | PF12661 | |
| Domain | - | 3.05e-08 | 95 | 96 | 8 | 2.60.120.200 | |
| Domain | VWC_out | 3.55e-08 | 19 | 96 | 5 | SM00215 | |
| Domain | VWC | 3.81e-08 | 38 | 96 | 6 | SM00214 | |
| Domain | VWF_dom | 7.11e-08 | 42 | 96 | 6 | IPR001007 | |
| Domain | ConA-like_dom | 1.87e-07 | 219 | 96 | 10 | IPR013320 | |
| Domain | EGF_LAM_2 | 4.16e-07 | 30 | 96 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 4.16e-07 | 30 | 96 | 5 | PS01248 | |
| Domain | EGF_Lam | 9.28e-07 | 35 | 96 | 5 | SM00180 | |
| Domain | VWFC_1 | 1.07e-06 | 36 | 96 | 5 | PS01208 | |
| Domain | VWFC_2 | 1.42e-06 | 38 | 96 | 5 | PS50184 | |
| Domain | Laminin_EGF | 1.42e-06 | 38 | 96 | 5 | IPR002049 | |
| Domain | Notch_dom | 4.54e-06 | 7 | 96 | 3 | IPR000800 | |
| Domain | Notch | 4.54e-06 | 7 | 96 | 3 | PF00066 | |
| Domain | NL | 4.54e-06 | 7 | 96 | 3 | SM00004 | |
| Domain | cEGF | 8.98e-06 | 26 | 96 | 4 | IPR026823 | |
| Domain | cEGF | 8.98e-06 | 26 | 96 | 4 | PF12662 | |
| Domain | - | 2.11e-05 | 11 | 96 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 2.11e-05 | 11 | 96 | 3 | IPR023413 | |
| Domain | Jagged/Serrate | 2.61e-05 | 2 | 96 | 2 | IPR026219 | |
| Domain | EGF_3 | 2.80e-05 | 12 | 96 | 3 | PF12947 | |
| Domain | EGF_dom | 2.80e-05 | 12 | 96 | 3 | IPR024731 | |
| Domain | Laminin_EGF | 3.04e-05 | 35 | 96 | 4 | PF00053 | |
| Domain | Laminin_N | 7.02e-05 | 16 | 96 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 7.02e-05 | 16 | 96 | 3 | PS51117 | |
| Domain | Laminin_N | 7.02e-05 | 16 | 96 | 3 | PF00055 | |
| Domain | LamNT | 7.02e-05 | 16 | 96 | 3 | SM00136 | |
| Domain | Thbs/COMP_coiled-coil | 7.82e-05 | 3 | 96 | 2 | IPR024665 | |
| Domain | DUF3454 | 7.82e-05 | 3 | 96 | 2 | PF11936 | |
| Domain | DUF3454_notch | 7.82e-05 | 3 | 96 | 2 | IPR024600 | |
| Domain | COMP | 7.82e-05 | 3 | 96 | 2 | PF11598 | |
| Domain | DUF3454 | 7.82e-05 | 3 | 96 | 2 | SM01334 | |
| Domain | - | 9.06e-05 | 46 | 96 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.07e-04 | 48 | 96 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.16e-04 | 49 | 96 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.16e-04 | 49 | 96 | 4 | IPR002172 | |
| Domain | LDLa | 1.16e-04 | 49 | 96 | 4 | SM00192 | |
| Domain | Notch | 1.56e-04 | 4 | 96 | 2 | IPR008297 | |
| Domain | NODP | 1.56e-04 | 4 | 96 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.56e-04 | 4 | 96 | 2 | IPR011656 | |
| Domain | DSL | 1.56e-04 | 4 | 96 | 2 | PF01414 | |
| Domain | Notch_NOD_dom | 1.56e-04 | 4 | 96 | 2 | IPR010660 | |
| Domain | NOD | 1.56e-04 | 4 | 96 | 2 | PF06816 | |
| Domain | DSL | 1.56e-04 | 4 | 96 | 2 | SM00051 | |
| Domain | NOD | 1.56e-04 | 4 | 96 | 2 | SM01338 | |
| Domain | NODP | 1.56e-04 | 4 | 96 | 2 | SM01339 | |
| Domain | TSPN | 2.16e-04 | 23 | 96 | 3 | SM00210 | |
| Domain | zf-C2H2 | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 2.23e-04 | 693 | 96 | 12 | PF00096 |
| Domain | Laminin_G | 2.25e-04 | 58 | 96 | 4 | IPR001791 | |
| Domain | Lysyl_oxidase | 2.59e-04 | 5 | 96 | 2 | IPR001695 | |
| Domain | DSL | 2.59e-04 | 5 | 96 | 2 | IPR001774 | |
| Domain | DSL | 2.59e-04 | 5 | 96 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 2.59e-04 | 5 | 96 | 2 | IPR011651 | |
| Domain | TSP_3 | 2.59e-04 | 5 | 96 | 2 | PF02412 | |
| Domain | LYSYL_OXIDASE | 2.59e-04 | 5 | 96 | 2 | PS00926 | |
| Domain | LNR | 2.59e-04 | 5 | 96 | 2 | PS50258 | |
| Domain | TSP3 | 2.59e-04 | 5 | 96 | 2 | PS51234 | |
| Domain | TSP_CTER | 2.59e-04 | 5 | 96 | 2 | PS51236 | |
| Domain | - | 2.59e-04 | 5 | 96 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.59e-04 | 5 | 96 | 2 | IPR008859 | |
| Domain | TSP_C | 2.59e-04 | 5 | 96 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 2.59e-04 | 5 | 96 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 2.59e-04 | 5 | 96 | 2 | IPR003367 | |
| Domain | Lysyl_oxidase_CS | 2.59e-04 | 5 | 96 | 2 | IPR019828 | |
| Domain | MNNL | 2.59e-04 | 5 | 96 | 2 | PF07657 | |
| Domain | TSP_type-3_rpt | 2.59e-04 | 5 | 96 | 2 | IPR028974 | |
| Domain | Lysyl_oxidase | 2.59e-04 | 5 | 96 | 2 | PF01186 | |
| Domain | Ephrin_rec_like | 2.79e-04 | 25 | 96 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.79e-04 | 25 | 96 | 3 | IPR011641 | |
| Domain | VWC | 3.93e-04 | 28 | 96 | 3 | PF00093 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 6.11e-04 | 775 | 96 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 6.25e-04 | 777 | 96 | 12 | PS00028 |
| Domain | LAMININ_IVA | 7.17e-04 | 8 | 96 | 2 | PS51115 | |
| Domain | Laminin_B | 7.17e-04 | 8 | 96 | 2 | PF00052 | |
| Domain | LamB | 7.17e-04 | 8 | 96 | 2 | SM00281 | |
| Domain | Laminin_IV | 7.17e-04 | 8 | 96 | 2 | IPR000034 | |
| Domain | - | ZNF555 MECOM ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 7.21e-04 | 679 | 96 | 11 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 7.72e-04 | 796 | 96 | 12 | IPR015880 |
| Domain | Znf_C2H2 | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 8.51e-04 | 805 | 96 | 12 | IPR007087 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF555 MECOM ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 8.62e-04 | 694 | 96 | 11 | IPR013087 |
| Domain | ZnF_C2H2 | ZNF555 MECOM POGZ ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 8.79e-04 | 808 | 96 | 12 | SM00355 |
| Domain | LDLR_class-A_CS | 1.13e-03 | 40 | 96 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 1.13e-03 | 40 | 96 | 3 | PF02210 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 3.00e-08 | 7 | 78 | 4 | M27199 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.34e-07 | 27 | 78 | 5 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.97e-07 | 13 | 78 | 4 | M47423 | |
| Pathway | PID_NOTCH_PATHWAY | 8.42e-07 | 59 | 78 | 6 | M17 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.13e-06 | 15 | 78 | 4 | M27202 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.88e-06 | 22 | 78 | 4 | M27210 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 2.44e-05 | 31 | 78 | 4 | M592 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.14e-05 | 33 | 78 | 4 | M604 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.46e-05 | 12 | 78 | 3 | M47532 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.62e-05 | 68 | 78 | 5 | M27303 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.00e-05 | 300 | 78 | 9 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.16e-05 | 39 | 78 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 8.66e-05 | 16 | 78 | 3 | M47424 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.91e-05 | 82 | 78 | 5 | MM15922 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.00e-04 | 84 | 78 | 5 | M7098 | |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 ARHGEF12 MECOM CASP9 LAMC1 LAMC2 JAG2 JAG1 ALK NOTCH1 NOTCH2 | 1.03e-04 | 507 | 78 | 11 | M48302 |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.05e-04 | 17 | 78 | 3 | M39389 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.09e-04 | 45 | 78 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.19e-04 | 46 | 78 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.29e-04 | 47 | 78 | 4 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.48e-04 | 19 | 78 | 3 | MM15594 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.52e-04 | 49 | 78 | 4 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.93e-04 | 58 | 78 | 4 | M29616 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.99e-04 | 5 | 78 | 2 | M27411 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.43e-04 | 25 | 78 | 3 | M27879 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.56e-04 | 61 | 78 | 4 | M39540 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.47e-04 | 6 | 78 | 2 | M27068 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.54e-04 | 258 | 78 | 7 | MM14572 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.94e-04 | 30 | 78 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.94e-04 | 30 | 78 | 3 | MM15812 | |
| Pathway | WP_AXON_GUIDANCE | 6.71e-04 | 72 | 78 | 4 | M48335 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 7.44e-04 | 74 | 78 | 4 | M616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.06e-03 | 9 | 78 | 2 | M47866 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 1.06e-03 | 9 | 78 | 2 | M39869 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.09e-03 | 82 | 78 | 4 | M594 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.17e-03 | 143 | 78 | 5 | M27275 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.20e-03 | 84 | 78 | 4 | M3228 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TRPC1 ARHGEF12 LAMC1 ADAM10 SPTBN5 SLIT2 NELL2 PLXNC1 ST8SIA2 EPHA4 | 1.22e-03 | 575 | 78 | 10 | M29853 |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.29e-03 | 39 | 78 | 3 | MM14601 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 1.32e-03 | 10 | 78 | 2 | M27348 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.32e-03 | 10 | 78 | 2 | MM14849 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 1.32e-03 | 10 | 78 | 2 | MM15839 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.61e-03 | 11 | 78 | 2 | M47865 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.61e-03 | 11 | 78 | 2 | M27882 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 1.61e-03 | 11 | 78 | 2 | M39647 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.61e-03 | 11 | 78 | 2 | M158 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.83e-03 | 44 | 78 | 3 | M26969 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.92e-03 | 12 | 78 | 2 | M47533 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.96e-03 | 96 | 78 | 4 | M39834 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 2.08e-03 | 46 | 78 | 3 | M48243 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 2.27e-03 | 13 | 78 | 2 | M39589 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.27e-03 | 13 | 78 | 2 | M47534 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.63e-03 | 14 | 78 | 2 | M27808 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.21e-03 | 261 | 78 | 6 | MM15676 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 24398584 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.96e-10 | 5 | 98 | 4 | 15064243 | |
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 10958687 | ||
| Pubmed | 2.06e-09 | 7 | 98 | 4 | 10383933 | ||
| Pubmed | 2.06e-09 | 7 | 98 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.06e-09 | 7 | 98 | 4 | 12846471 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.29e-09 | 248 | 98 | 10 | 24006456 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 4.11e-09 | 8 | 98 | 4 | 22652674 | |
| Pubmed | 4.11e-09 | 8 | 98 | 4 | 9858718 | ||
| Pubmed | 4.11e-09 | 8 | 98 | 4 | 11044610 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ACOT7 LAMC1 GRN ADAM12 JAG2 SLIT2 NELL1 NELL2 GPSM2 LTBP1 FHL3 NOTCH1 NOTCH2 | 6.57e-09 | 560 | 98 | 13 | 21653829 |
| Pubmed | 7.39e-09 | 9 | 98 | 4 | 11118901 | ||
| Pubmed | 7.39e-09 | 9 | 98 | 4 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.23e-08 | 10 | 98 | 4 | 23665443 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.93e-08 | 11 | 98 | 4 | 9187150 | |
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 10878608 | ||
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 12866128 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 2.17e-08 | 3 | 98 | 3 | 14726396 | |
| Pubmed | Notch signaling drives multiple myeloma induced osteoclastogenesis. | 2.17e-08 | 3 | 98 | 3 | 25257302 | |
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 2.17e-08 | 3 | 98 | 3 | 18458347 | |
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 2.17e-08 | 3 | 98 | 3 | 37330998 | |
| Pubmed | 2.88e-08 | 12 | 98 | 4 | 15465494 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 4.16e-08 | 13 | 98 | 4 | 31202705 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.16e-08 | 13 | 98 | 4 | 11578869 | |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 14757642 | ||
| Pubmed | 7.90e-08 | 15 | 98 | 4 | 12971992 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 7.90e-08 | 15 | 98 | 4 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 7.90e-08 | 15 | 98 | 4 | 16914494 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 10837254 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 8.66e-08 | 4 | 98 | 3 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 8.66e-08 | 4 | 98 | 3 | 30226866 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 10551863 | ||
| Pubmed | ADAM10 mediates ectopic proximal tubule development and renal fibrosis through Notch signalling. | 8.66e-08 | 4 | 98 | 3 | 32715474 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 9858728 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 9315665 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 28745029 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 20819128 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 8.66e-08 | 4 | 98 | 3 | 20040020 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.05e-07 | 16 | 98 | 4 | 12617809 | |
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 1.05e-07 | 16 | 98 | 4 | 27641601 | |
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 10842072 | ||
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 32161758 | ||
| Pubmed | 1.11e-07 | 41 | 98 | 5 | 22675208 | ||
| Pubmed | 1.37e-07 | 17 | 98 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.37e-07 | 17 | 98 | 4 | 15821257 | |
| Pubmed | 1.76e-07 | 18 | 98 | 4 | 18093989 | ||
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 1.76e-07 | 18 | 98 | 4 | 36899896 | |
| Pubmed | 1.76e-07 | 18 | 98 | 4 | 15689374 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 11713346 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 12175503 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 2.16e-07 | 5 | 98 | 3 | 11006133 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 27084580 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 15882997 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 27118257 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 35064244 | ||
| Pubmed | 2.22e-07 | 19 | 98 | 4 | 25691540 | ||
| Pubmed | 2.22e-07 | 19 | 98 | 4 | 21302255 | ||
| Pubmed | 2.22e-07 | 19 | 98 | 4 | 16518823 | ||
| Pubmed | 2.49e-07 | 48 | 98 | 5 | 35247391 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 2.77e-07 | 20 | 98 | 4 | 29961574 | |
| Pubmed | 3.42e-07 | 21 | 98 | 4 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 3.42e-07 | 21 | 98 | 4 | 14702043 | |
| Pubmed | 3.42e-07 | 21 | 98 | 4 | 14651921 | ||
| Pubmed | 4.17e-07 | 22 | 98 | 4 | 21750033 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 4.31e-07 | 6 | 98 | 3 | 12244553 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 15226394 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 22526456 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 4.31e-07 | 6 | 98 | 3 | 19603167 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 9108364 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 31071093 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.38e-07 | 101 | 98 | 6 | 23382219 | |
| Pubmed | 5.04e-07 | 23 | 98 | 4 | 14701881 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 5.04e-07 | 23 | 98 | 4 | 23386589 | |
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 6.03e-07 | 24 | 98 | 4 | 21420948 | |
| Pubmed | 7.11e-07 | 59 | 98 | 5 | 21421844 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 7.16e-07 | 25 | 98 | 4 | 17170699 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 7.53e-07 | 7 | 98 | 3 | 24711412 | |
| Pubmed | Evidence for a Notch1-mediated transition during olfactory ensheathing cell development. | 7.53e-07 | 7 | 98 | 3 | 27271278 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 16169548 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 8.45e-07 | 26 | 98 | 4 | 19369401 | |
| Pubmed | A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. | 9.90e-07 | 27 | 98 | 4 | 29956664 | |
| Pubmed | 1.10e-06 | 118 | 98 | 6 | 21078624 | ||
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.20e-06 | 8 | 98 | 3 | 15465493 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 15068794 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 19914235 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.20e-06 | 8 | 98 | 3 | 12242716 | |
| Pubmed | 1.33e-06 | 29 | 98 | 4 | 25535917 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 1.33e-06 | 29 | 98 | 4 | 21402740 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.54e-06 | 30 | 98 | 4 | 24552588 | |
| Pubmed | 1.54e-06 | 30 | 98 | 4 | 16524929 | ||
| Pubmed | 1.76e-06 | 31 | 98 | 4 | 37573008 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 1.80e-06 | 9 | 98 | 3 | 11944948 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 1.80e-06 | 9 | 98 | 3 | 10837027 | |
| Pubmed | Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. | 2.28e-06 | 33 | 98 | 4 | 16000382 | |
| Pubmed | Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress. | 2.57e-06 | 10 | 98 | 3 | 26542370 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 24015274 | ||
| Pubmed | 2.58e-06 | 34 | 98 | 4 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 2.90e-06 | 35 | 98 | 4 | 21252157 | |
| Interaction | FBXO2 interactions | CACNA2D2 LAMC1 LAMC2 GRN ADAM10 JAG2 SLIT2 NELL2 PLXNC1 LOXL2 JAG1 SYNE2 LRP2 NOTCH1 NOTCH2 | 8.51e-10 | 411 | 95 | 15 | int:FBXO2 |
| Interaction | IGFL3 interactions | 6.32e-08 | 75 | 95 | 7 | int:IGFL3 | |
| Interaction | NTN5 interactions | 8.29e-08 | 24 | 95 | 5 | int:NTN5 | |
| Interaction | HOXA1 interactions | ACOT7 CFP GRN ADAM12 JAG2 SLIT2 NELL1 NELL2 LTBP1 FHL3 NOTCH1 | 9.30e-07 | 356 | 95 | 11 | int:HOXA1 |
| Interaction | EGFL7 interactions | 1.69e-06 | 77 | 95 | 6 | int:EGFL7 | |
| Interaction | SIRPD interactions | 3.25e-06 | 86 | 95 | 6 | int:SIRPD | |
| Interaction | GFI1B interactions | 3.68e-06 | 136 | 95 | 7 | int:GFI1B | |
| Interaction | ZFP41 interactions | 7.22e-06 | 57 | 95 | 5 | int:ZFP41 | |
| Interaction | PRG2 interactions | 8.10e-06 | 285 | 95 | 9 | int:PRG2 | |
| Interaction | TNNC2 interactions | 1.10e-05 | 62 | 95 | 5 | int:TNNC2 | |
| Interaction | CACNA1A interactions | 2.55e-05 | 123 | 95 | 6 | int:CACNA1A | |
| Interaction | NOTCH2 interactions | 3.08e-05 | 423 | 95 | 10 | int:NOTCH2 | |
| Interaction | MBD1 interactions | 3.16e-05 | 77 | 95 | 5 | int:MBD1 | |
| Interaction | JAG1 interactions | 4.11e-05 | 41 | 95 | 4 | int:JAG1 | |
| Interaction | SLURP1 interactions | 6.18e-05 | 144 | 95 | 6 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 6.42e-05 | 145 | 95 | 6 | int:ZNF408 | |
| Interaction | TIMP3 interactions | 6.70e-05 | 90 | 95 | 5 | int:TIMP3 | |
| Interaction | WNT3A interactions | 8.34e-05 | 49 | 95 | 4 | int:WNT3A | |
| Interaction | MFAP5 interactions | 1.05e-04 | 52 | 95 | 4 | int:MFAP5 | |
| Interaction | LGALS1 interactions | 1.75e-04 | 332 | 95 | 8 | int:LGALS1 | |
| GeneFamily | Laminin subunits | 1.53e-05 | 12 | 76 | 3 | 626 | |
| GeneFamily | CD molecules|Mucins | 8.99e-05 | 21 | 76 | 3 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF555 MECOM ZNF223 ZNF557 ZNF10 ZNF19 ZNF425 ZBTB21 ZNF333 ZBTB18 ZNF292 | 1.95e-04 | 718 | 76 | 11 | 28 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 COMP LAMC1 LAMC2 RSPO4 MATN4 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 LTBP1 | 4.12e-13 | 196 | 97 | 13 | M3008 |
| Coexpression | NABA_MATRISOME | PAPPA2 LAMB4 COMP LAMC1 LAMC2 RSPO4 LGALS12 MATN4 MUC5B ADAM12 ADAM10 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 PLXNC1 LOXL2 LOXL4 LTBP1 MUC3A | 2.39e-12 | 1026 | 97 | 23 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | COMP LAMC1 LAMC2 RSPO4 MATN4 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 LTBP1 | 6.58e-12 | 191 | 97 | 12 | MM17059 |
| Coexpression | NABA_MATRISOME | PAPPA2 COMP LAMC1 LAMC2 RSPO4 LGALS12 MATN4 MUC5B MFRP ADAM12 ADAM10 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 SCUBE2 PLXNC1 LOXL2 LOXL4 LTBP1 | 1.31e-11 | 1008 | 97 | 22 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 COMP LAMC1 LAMC2 RSPO4 MATN4 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 LTBP1 | 2.99e-11 | 275 | 97 | 13 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COMP LAMC1 LAMC2 RSPO4 MATN4 SVEP1 SLIT2 NELL1 NELL2 THBS3 NTNG2 LTBP1 | 3.67e-10 | 270 | 97 | 12 | MM17057 |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 8.61e-08 | 99 | 97 | 7 | M768 | |
| Coexpression | DELYS_THYROID_CANCER_UP | PCSK2 COMP ACOT7 BCAT1 LAMC2 ADAM12 RYR1 NELL2 PLXNC1 LOXL2 EPHA4 NCKAP1L | 9.59e-08 | 445 | 97 | 12 | M3645 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.10e-07 | 16 | 97 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.10e-07 | 16 | 97 | 4 | M2207 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 2.71e-06 | 8 | 97 | 3 | M9884 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRPC1 MBNL1 MECOM LAMC1 ADAM10 SLIT2 ATP2C1 UBR5 SYNE2 AKAP11 CDC27 ZBTB18 EPHA4 ZNF292 | 3.20e-06 | 856 | 97 | 14 | M4500 |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 8.55e-06 | 196 | 97 | 7 | M8683 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | CACNA2D2 MECOM LAMC2 MATN4 SIX4 SVEP1 NELL1 SCUBE2 ANLN JAG1 ST8SIA2 LRP2 LOXL4 FHL3 NOTCH1 | 9.30e-06 | 1074 | 97 | 15 | M1941 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 9.75e-06 | 200 | 97 | 7 | M5930 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.45e-05 | 40 | 97 | 4 | M5887 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | GABRE ARHGEF12 LAMC1 GRN DBH MFRP ADAM12 SVEP1 LIMS1 LOXL2 JAG1 NOTCH2 | 3.75e-05 | 795 | 97 | 12 | M39050 |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 4.51e-05 | 105 | 97 | 5 | M12602 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 5.02e-05 | 176 | 97 | 6 | M8881 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 6.08e-05 | 362 | 97 | 8 | M39176 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 6.86e-05 | 59 | 97 | 4 | M10156 | |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 7.89e-05 | 191 | 97 | 6 | M2148 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 9.51e-05 | 286 | 97 | 7 | M45746 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 9.62e-05 | 198 | 97 | 6 | M9386 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 9.89e-05 | 199 | 97 | 6 | M7619 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 1.07e-04 | 25 | 97 | 3 | M9946 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | LAMB4 COMP TRPC1 PAQR8 MECOM BCAT1 LAMC1 RFX6 SIX4 JAG2 PLXNC1 EPHA4 | 1.11e-04 | 891 | 97 | 12 | M45033 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.27e-04 | 69 | 97 | 4 | M10165 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 1.98e-04 | 322 | 97 | 7 | M39060 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.25e-04 | 438 | 97 | 8 | M1954 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.25e-04 | 32 | 97 | 3 | M5903 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.32e-04 | 440 | 97 | 8 | MM832 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 2.75e-04 | 340 | 97 | 7 | M2012 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 CACNA2D2 TAGAP PPM1K ANKRD50 ADAM12 SVEP1 SLIT2 PLXNC1 ANLN LOXL2 JAG1 SYNE2 ST8SIA2 NOTCH2 | 1.17e-06 | 768 | 93 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | PAPPA2 MECOM LAMC1 LAMC2 SLIT2 JAG1 LRP2 LTBP1 NOTCH1 NOTCH2 EPHA4 | 1.35e-06 | 398 | 93 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | PAPPA2 CACNA2D2 ARHGEF12 MECOM LAMC1 LAMC2 SLIT2 NELL2 JAG1 LRP2 POLR1B LTBP1 NOTCH1 NOTCH2 EPHA4 | 1.49e-06 | 783 | 93 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 TAGAP PPM1K ANKRD50 ADAM12 SVEP1 SLIT2 PLXNC1 ANLN LOXL2 JAG1 SYNE2 ST8SIA2 NOTCH2 | 6.59e-06 | 773 | 93 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 7.68e-06 | 62 | 93 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 8.14e-06 | 165 | 93 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 9.70e-06 | 65 | 93 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.20e-05 | 175 | 93 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | GABRE PAPPA2 MECOM SLIT2 NELL2 NTNG2 PLXNC1 SYNE2 ST8SIA2 LRP2 GPSM2 LTBP1 ZBTB18 EPHA4 ZNF292 | 2.37e-05 | 986 | 93 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 4.79e-05 | 148 | 93 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_500 | 8.61e-05 | 102 | 93 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 9.06e-05 | 166 | 93 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | ARHGEF12 MECOM LAMC1 LAMC2 SLIT2 NELL1 JAG1 POLR1B LTBP1 NOTCH1 NOTCH2 EPHA4 | 1.03e-04 | 749 | 93 | 12 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.32e-04 | 439 | 93 | 9 | GSM777059_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | PAPPA2 PCSK2 TRPC1 MECOM LAMC1 LAMC2 ADGRL4 LOXL2 JAG1 LRP2 LTBP1 HEATR5B NOTCH2 | 1.55e-04 | 905 | 93 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.70e-04 | 356 | 93 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | CACNA2D2 MECOM LAMC1 LAMC2 DUS1L SCUBE2 JAG1 LRP2 LTBP1 NOTCH1 EPHA4 TRMT12 | 2.16e-04 | 811 | 93 | 12 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 2.21e-04 | 370 | 93 | 8 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PAPPA2 TAGAP PPM1K SVEP1 SLIT2 PLXNC1 ANLN LOXL2 SYNE2 ST8SIA2 LTBP1 NOTCH2 | 2.59e-04 | 827 | 93 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.01e-04 | 207 | 93 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.05e-04 | 293 | 93 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.42e-04 | 212 | 93 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.28e-04 | 310 | 93 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.65e-04 | 82 | 93 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_1000 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 195 | 97 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 195 | 97 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.55e-07 | 197 | 97 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-07 | 199 | 97 | 7 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-07 | 199 | 97 | 7 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.44e-06 | 161 | 97 | 6 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-06 | 179 | 97 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 180 | 97 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 180 | 97 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.85e-06 | 181 | 97 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 187 | 97 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 190 | 97 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 190 | 97 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.88e-06 | 191 | 97 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 191 | 97 | 6 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-06 | 191 | 97 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 192 | 97 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 192 | 97 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.00e-06 | 192 | 97 | 6 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 192 | 97 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 192 | 97 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.37e-06 | 195 | 97 | 6 | 75db19c0371320ea5fce1d6de8c1b40b1e6a2e58 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.63e-06 | 197 | 97 | 6 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 198 | 97 | 6 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-06 | 198 | 97 | 6 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 4.91e-06 | 199 | 97 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 4.91e-06 | 199 | 97 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.05e-06 | 200 | 97 | 6 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.05e-06 | 200 | 97 | 6 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.05e-06 | 200 | 97 | 6 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.88e-05 | 149 | 97 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-05 | 161 | 97 | 5 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 166 | 97 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 166 | 97 | 5 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 166 | 97 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.44e-05 | 169 | 97 | 5 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-05 | 169 | 97 | 5 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-05 | 170 | 97 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.53e-05 | 170 | 97 | 5 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-05 | 170 | 97 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 170 | 97 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 171 | 97 | 5 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 171 | 97 | 5 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 172 | 97 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 172 | 97 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.84e-05 | 173 | 97 | 5 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 174 | 97 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-05 | 175 | 97 | 5 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.06e-05 | 175 | 97 | 5 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-05 | 175 | 97 | 5 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 176 | 97 | 5 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 176 | 97 | 5 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.40e-05 | 178 | 97 | 5 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.52e-05 | 179 | 97 | 5 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.52e-05 | 179 | 97 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.52e-05 | 179 | 97 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 181 | 97 | 5 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-05 | 181 | 97 | 5 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-05 | 181 | 97 | 5 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-05 | 181 | 97 | 5 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 181 | 97 | 5 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 182 | 97 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 182 | 97 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 182 | 97 | 5 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.02e-05 | 183 | 97 | 5 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-05 | 184 | 97 | 5 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 185 | 97 | 5 | 0149981d3818a6250f32c08456c28e7037c39d91 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-05 | 185 | 97 | 5 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.42e-05 | 186 | 97 | 5 | 72f7427d62d65e37bb0bf99229a1b75df081a128 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.42e-05 | 186 | 97 | 5 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 186 | 97 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-05 | 186 | 97 | 5 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.42e-05 | 186 | 97 | 5 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-05 | 186 | 97 | 5 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 187 | 97 | 5 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 187 | 97 | 5 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.70e-05 | 188 | 97 | 5 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.70e-05 | 188 | 97 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 188 | 97 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 188 | 97 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 188 | 97 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 189 | 97 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 189 | 97 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 189 | 97 | 5 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 189 | 97 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 190 | 97 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 190 | 97 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.99e-05 | 190 | 97 | 5 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.99e-05 | 190 | 97 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 190 | 97 | 5 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.11e-07 | 161 | 96 | 8 | 3556_DN | |
| Drug | LMWH | PAPPA2 LAMB4 LAMC1 LAMC2 CFP MFRP ADAM12 RYR1 ADGRL4 SLIT2 THBS3 LRP2 POLN EPHA4 | 7.28e-07 | 663 | 96 | 14 | CID000000772 |
| Drug | 3-amino-2-oxazolidinone | 5.99e-06 | 9 | 96 | 3 | CID000065725 | |
| Drug | FLA 365 | 5.99e-06 | 9 | 96 | 3 | CID000072776 | |
| Drug | safrazine | 8.53e-06 | 10 | 96 | 3 | CID000034041 | |
| Drug | AC1L1G72 | 1.17e-05 | 11 | 96 | 3 | CID000003553 | |
| Drug | 4-hydroxy-3-methoxyphenylglycol-piperazine | 1.17e-05 | 11 | 96 | 3 | CID002723890 | |
| Drug | pheniprazine | 1.55e-05 | 12 | 96 | 3 | CID000005929 | |
| Drug | almotriptan | 1.96e-05 | 38 | 96 | 4 | CID000123606 | |
| Drug | 3-methoxytyramine | 1.96e-05 | 38 | 96 | 4 | CID000001669 | |
| Drug | styrene | 1.99e-05 | 78 | 96 | 5 | CID000007501 | |
| Drug | SKF 64139 | 2.01e-05 | 13 | 96 | 3 | CID000123919 | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 5616_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 4804_UP | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 6681_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 6687_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.17e-05 | 199 | 96 | 7 | 3205_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.17e-05 | 199 | 96 | 7 | 3096_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.17e-05 | 199 | 96 | 7 | 6105_UP | |
| Drug | benzylhydrazine | 2.56e-05 | 14 | 96 | 3 | CID000011157 | |
| Drug | lead stearate | 2.85e-05 | 84 | 96 | 5 | CID000061258 | |
| Drug | MFMD | 3.19e-05 | 15 | 96 | 3 | CID000122302 | |
| Drug | anad | 3.19e-05 | 15 | 96 | 3 | CID005287574 | |
| Drug | methoxytyramine | 3.91e-05 | 16 | 96 | 3 | CID000068384 | |
| Drug | NSC142627 | 4.73e-05 | 17 | 96 | 3 | CID000422254 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.06e-05 | 155 | 96 | 6 | 6817_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 6.03e-05 | 160 | 96 | 6 | 6133_DN | |
| Drug | norfenefrine | 6.70e-05 | 19 | 96 | 3 | CID000004538 | |
| Drug | Rgd Peptide | 6.94e-05 | 239 | 96 | 7 | CID000104802 | |
| Drug | nialamide | 9.14e-05 | 21 | 96 | 3 | CID000004472 | |
| Drug | MHPG | 9.88e-05 | 57 | 96 | 4 | CID000010805 | |
| Drug | coprine | 1.06e-04 | 22 | 96 | 3 | CID000108079 | |
| Drug | P LZ | 1.06e-04 | 22 | 96 | 3 | CID016040275 | |
| Drug | harmine | 1.06e-04 | 22 | 96 | 3 | CID000022382 | |
| Drug | nickel | 1.13e-04 | 552 | 96 | 10 | CID000000934 | |
| Drug | panobinostat | RTP1 MECOM CASP9 LAMC2 PPM1K ADAM12 ZRANB3 SLIT2 NELL1 NELL2 SCUBE2 PLXNC1 ST8SIA2 LRP2 MUC3A EPHA4 | 1.36e-04 | 1333 | 96 | 16 | ctd:C496932 |
| Drug | A25152 | 1.37e-04 | 62 | 96 | 4 | CID000002956 | |
| Drug | yessotoxin | 1.38e-04 | 24 | 96 | 3 | CID006440821 | |
| Drug | beta-carboline | 1.55e-04 | 64 | 96 | 4 | CID000064961 | |
| Drug | harmane | 1.55e-04 | 64 | 96 | 4 | CID005281404 | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 1.64e-04 | 192 | 96 | 6 | 1634_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 3213_UP | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.74e-04 | 194 | 96 | 6 | 3689_DN | |
| Drug | amiguanidine | 1.74e-04 | 5 | 96 | 2 | CID000364439 | |
| Drug | cobalt salts | 1.74e-04 | 5 | 96 | 2 | CID000026868 | |
| Drug | chromotropic acid | 1.74e-04 | 5 | 96 | 2 | CID000067220 | |
| Drug | OR-486 | 1.76e-04 | 26 | 96 | 3 | CID001810907 | |
| Drug | FLA-63 | 1.76e-04 | 26 | 96 | 3 | CID000033295 | |
| Drug | Ro 4-1284 | 1.76e-04 | 26 | 96 | 3 | CID000009345 | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 5673_UP | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 2156_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.79e-04 | 195 | 96 | 6 | 4373_DN | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 1.79e-04 | 195 | 96 | 6 | 630_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A | 1.79e-04 | 195 | 96 | 6 | 1431_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 3766_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 3789_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A | 1.84e-04 | 196 | 96 | 6 | 2031_DN | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 6873_DN | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 6633_UP | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 2051_DN | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 6607_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 5606_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 3892_DN | |
| Drug | Gleevec; Up 200; 10uM; PC3; HG-U133A | 1.84e-04 | 196 | 96 | 6 | 483_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.84e-04 | 196 | 96 | 6 | 2562_UP | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 4796_UP | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 1.89e-04 | 197 | 96 | 6 | 484_UP | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 1.89e-04 | 197 | 96 | 6 | 255_UP | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 2222_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 6306_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 197 | 96 | 6 | 4797_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2431_UP | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2732_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2171_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2809_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 4392_UP | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 3185_UP | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 2400_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-04 | 198 | 96 | 6 | 6239_DN | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 3636_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 6444_UP | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 6357_UP | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 7274_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 4115_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 199 | 96 | 6 | 5541_DN | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 5744_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 5621_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 6509_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 2.05e-04 | 200 | 96 | 6 | 665_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 4006_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 200 | 96 | 6 | 3240_DN | |
| Drug | AC1L1B58 | 2.45e-04 | 29 | 96 | 3 | CID000001288 | |
| Drug | dhmal | 2.45e-04 | 29 | 96 | 3 | CID000151725 | |
| Drug | T 794 | 2.61e-04 | 6 | 96 | 2 | CID003077680 | |
| Drug | NSD 2023 | 2.61e-04 | 6 | 96 | 2 | CID000019831 | |
| Drug | 1-benzyl-2-methyl-5-methoxytryptamine | 2.61e-04 | 6 | 96 | 2 | CID000009925 | |
| Drug | BU99006 | 2.61e-04 | 6 | 96 | 2 | CID006603748 | |
| Drug | 5-hydroxyisatin | 2.61e-04 | 6 | 96 | 2 | CID010352011 | |
| Drug | 1-PCPA | 2.61e-04 | 6 | 96 | 2 | CID000194548 | |
| Drug | N-cyclopropyl-5,6-dimethoxytryptamine | 2.61e-04 | 6 | 96 | 2 | CID000156277 | |
| Disease | Malignant neoplasm of breast | RTP1 MECOM CFP SIX4 ADAM12 ADAM10 JAG2 THBS3 LOXL2 JAG1 SYNE2 CDC27 ALK NOTCH1 NOTCH2 | 1.96e-06 | 1074 | 96 | 15 | C0006142 |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 7.19e-06 | 12 | 96 | 3 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | Hepatic ductular hypoplasia | 1.05e-05 | 2 | 96 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.05e-05 | 2 | 96 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 1.05e-05 | 2 | 96 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.05e-05 | 2 | 96 | 2 | C1956125 | |
| Disease | laminin subunit gamma-2 measurement | 1.05e-05 | 2 | 96 | 2 | EFO_0801756 | |
| Disease | Alagille Syndrome | 1.05e-05 | 2 | 96 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.05e-05 | 2 | 96 | 2 | cv:C0085280 | |
| Disease | cortical thickness | ARHGEF12 MECOM LAMC1 LGALS12 ADAM12 ADAM10 JAG2 SLIT2 NELL1 NELL2 THBS3 PLXNC1 JAG1 EPHA4 | 1.46e-05 | 1113 | 96 | 14 | EFO_0004840 |
| Disease | Carcinoma of bladder | 2.63e-05 | 18 | 96 | 3 | C0699885 | |
| Disease | Prostatic Neoplasms | 3.29e-05 | 616 | 96 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.29e-05 | 616 | 96 | 10 | C0376358 | |
| Disease | Carcinoma, Pancreatic Ductal | 6.43e-05 | 24 | 96 | 3 | C0887833 | |
| Disease | radiation-induced disorder | 6.89e-05 | 67 | 96 | 4 | EFO_0009565 | |
| Disease | brain cancer (implicated_via_orthology) | 8.22e-05 | 26 | 96 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Glioblastoma | 1.31e-04 | 79 | 96 | 4 | C0017636 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.42e-04 | 152 | 96 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 1.56e-04 | 6 | 96 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 1.66e-04 | 84 | 96 | 4 | C0334588 | |
| Disease | Stage IV Skin Melanoma | 2.18e-04 | 7 | 96 | 2 | C1321872 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.18e-04 | 7 | 96 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.18e-04 | 7 | 96 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | body weight | PAPPA2 INTS12 MBNL1 ARHGEF12 MECOM SLIT2 NELL1 NTNG2 ANLN DLEU7 LTBP1 POLN EPHA4 | 2.23e-04 | 1261 | 96 | 13 | EFO_0004338 |
| Disease | pulmonary function measurement, forced expiratory volume | 2.39e-04 | 37 | 96 | 3 | EFO_0003892, EFO_0004314 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 2.78e-04 | 96 | 96 | 4 | EFO_0009369 | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 2.90e-04 | 8 | 96 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | cardiovascular measurement, left ventricular function | 2.90e-04 | 8 | 96 | 2 | EFO_0004295, EFO_0004298 | |
| Disease | Mammary Carcinoma, Human | 3.21e-04 | 525 | 96 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.21e-04 | 525 | 96 | 8 | C1257931 | |
| Disease | corpus callosum volume measurement | 3.25e-04 | 100 | 96 | 4 | EFO_0010299 | |
| Disease | Mammary Neoplasms | 3.29e-04 | 527 | 96 | 8 | C1458155 | |
| Disease | interleukin 9 measurement | 3.75e-04 | 43 | 96 | 3 | EFO_0008192 | |
| Disease | Breast Carcinoma | 3.78e-04 | 538 | 96 | 8 | C0678222 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.50e-04 | 195 | 96 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | promotilin measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0801930 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0021020 | |
| Disease | Glioblastoma Multiforme | 4.83e-04 | 111 | 96 | 4 | C1621958 | |
| Disease | neutrophil count | PAPPA2 TAGAP MBNL1 ASH1L ARHGEF12 MECOM POGZ ZRANB3 ADGRL4 JAG2 AKAP11 NOTCH2 ZNF292 | 5.34e-04 | 1382 | 96 | 13 | EFO_0004833 |
| Disease | cigarettes per day measurement | 5.80e-04 | 438 | 96 | 7 | EFO_0006525 | |
| Disease | Schizophrenia | 6.06e-04 | 883 | 96 | 10 | C0036341 | |
| Disease | FEV/FEC ratio | INTS12 MECOM LAMC2 RFX6 DBH ADAM12 ARMC2 SPTBN5 NELL2 THBS3 SYNE2 LTBP1 | 6.36e-04 | 1228 | 96 | 12 | EFO_0004713 |
| Disease | urate measurement | ASH1L MECOM CASP9 PPM1K THBS3 JAG1 LRP2 HEATR5B NOTCH2 EPHA4 | 6.72e-04 | 895 | 96 | 10 | EFO_0004531 |
| Disease | vital capacity | PAPPA2 INTS12 CACNA2D2 MBNL1 MECOM SIX4 SVEP1 ADGRL4 LRP2 DLEU7 LTBP1 FHL3 | 6.73e-04 | 1236 | 96 | 12 | EFO_0004312 |
| Disease | cataract (biomarker_via_orthology) | 7.98e-04 | 13 | 96 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | diacylglycerol 42:7 measurement | 9.29e-04 | 14 | 96 | 2 | EFO_0020068 | |
| Disease | myeloid white cell count | TAGAP MBNL1 ARHGEF12 MECOM ADGRL4 JAG2 POLR1B AKAP11 NOTCH2 ZNF292 | 9.53e-04 | 937 | 96 | 10 | EFO_0007988 |
| Disease | serum metabolite measurement | 1.02e-03 | 945 | 96 | 10 | EFO_0005653 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.07e-03 | 15 | 96 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.07e-03 | 15 | 96 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.07e-03 | 15 | 96 | 2 | C0154091 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.20e-03 | 64 | 96 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.22e-03 | 16 | 96 | 2 | C0334634 | |
| Disease | glycochenodeoxycholate measurement | 1.38e-03 | 17 | 96 | 2 | EFO_0010490 | |
| Disease | sphingomyelin 14:0 measurement | 1.38e-03 | 17 | 96 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.38e-03 | 17 | 96 | 2 | OBA_2045173 | |
| Disease | cortical surface area measurement | ARHGEF12 MECOM LAMC1 LGALS12 ADAM12 SVEP1 JAG2 SLIT2 NELL1 JAG1 ZBTB18 EPHA4 | 1.39e-03 | 1345 | 96 | 12 | EFO_0010736 |
| Disease | serum hepcidin measurement | 1.55e-03 | 18 | 96 | 2 | EFO_0004504 | |
| Disease | anorexia nervosa | 1.56e-03 | 70 | 96 | 3 | MONDO_0005351 | |
| Disease | hematocrit | 1.68e-03 | 1011 | 96 | 10 | EFO_0004348 | |
| Disease | Hypertriglyceridemia | 1.73e-03 | 19 | 96 | 2 | EFO_0004211 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.75e-03 | 157 | 96 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | taurocholate measurement | 1.92e-03 | 20 | 96 | 2 | EFO_0010538 | |
| Disease | brain measurement, neuroimaging measurement | 2.15e-03 | 550 | 96 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | memory performance | 2.22e-03 | 409 | 96 | 6 | EFO_0004874 | |
| Disease | Splenomegaly | 2.32e-03 | 22 | 96 | 2 | C0038002 | |
| Disease | progranulin measurement | 2.32e-03 | 22 | 96 | 2 | EFO_0004625 | |
| Disease | prostate carcinoma | 2.50e-03 | 891 | 96 | 9 | EFO_0001663 | |
| Disease | congenital heart disease (is_implicated_in) | 2.76e-03 | 24 | 96 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | HDL cholesterol change measurement | 2.76e-03 | 24 | 96 | 2 | EFO_0007805 | |
| Disease | periodontal measurement | 2.76e-03 | 24 | 96 | 2 | EFO_0007780 | |
| Disease | Cerebral Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0750936 | |
| Disease | Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.99e-03 | 25 | 96 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 2.99e-03 | 25 | 96 | 2 | C0338070 | |
| Disease | left ventricular structural measurement | 3.00e-03 | 88 | 96 | 3 | EFO_0008205 | |
| Disease | gastric carcinoma | 3.10e-03 | 89 | 96 | 3 | EFO_0000178 | |
| Disease | Gemistocytic astrocytoma | 3.24e-03 | 26 | 96 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.24e-03 | 26 | 96 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.24e-03 | 26 | 96 | 2 | C0334582 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCNSQNGERCVAALA | 91 | O00154 | |
| VNANCHLDNVCIAAN | 111 | Q9HBW9 | |
| EDLNLGHVCQNRDCQ | 701 | Q68DN1 | |
| NEARFINHSCDPNCE | 2216 | Q9NR48 | |
| LFAQCEAVDNGCQQV | 231 | P54687 | |
| AIIDCGNCSRLFHAQ | 1031 | Q9NY47 | |
| NFTDCNRHTQVCING | 551 | O14672 | |
| LDAQHQDICFSACGV | 726 | Q8NEN0 | |
| QVCTDINECETGQHN | 176 | P49747 | |
| FCHDNQTCCRDNRQG | 526 | P28799 | |
| FANGNIQCLQDVERC | 206 | Q6P1R4 | |
| CFCQTDIGGDRIHEN | 466 | Q9UKA4 | |
| NRQCQNISVFGVHEC | 646 | O43184 | |
| CLIGCGANINHTDQD | 596 | Q9ULJ7 | |
| EQDAETNRQCQFTCH | 126 | Q58WW2 | |
| EAGCVCNDAVIRNNT | 406 | P98194 | |
| EHEQINGQCSCFQSI | 361 | Q9NZN5 | |
| FARAAIAQCHQTGCV | 721 | Q7Z5Q5 | |
| AVCNQHCDIDRFQGA | 4971 | Q9HC84 | |
| SQEICDFVNQCHDPN | 306 | Q8N3J5 | |
| HCQCILDNAINGNFE | 271 | Q8HWS3 | |
| ASGNQLVECQECHNL | 171 | Q96CB8 | |
| CHLCDRCFGQQTNLD | 971 | Q03112 | |
| VCQEAEHQCQSGLAL | 541 | Q9BY79 | |
| EIDNRQCVQDSDHCF | 1626 | Q04721 | |
| SQNGCQHENDAAVRC | 396 | Q96JB6 | |
| HNGRCLDKINEFQCE | 501 | P46531 | |
| GNFDEAIVCCQRHLD | 116 | P81274 | |
| HCQVGFVLQQDQRSC | 281 | O95460 | |
| FCFVECHNRADAENA | 81 | A6PVI3 | |
| HNCDENALCFNTVGG | 491 | Q99435 | |
| DGFVQCDSRANCINL | 561 | Q99435 | |
| GQQFDRDLNAAHQCL | 171 | Q6UYE1 | |
| INCHINVNDCRGQCQ | 456 | Q9Y219 | |
| QASQALNCCVDEEHG | 736 | Q9NQW6 | |
| SQGCNHEEDAGVRCN | 411 | Q9Y4K0 | |
| LCNAGHEERSGECQA | 261 | P54764 | |
| FNDIAVGAVCCRVDH | 51 | Q9GZZ1 | |
| CTFQGDCVHSENLEN | 481 | O60486 | |
| LDAHRFQVDFQCGCS | 71 | Q96DT0 | |
| AHGQCRNTEGSFQCV | 1131 | Q14766 | |
| SGVDNAIDCHQGQCV | 3181 | Q02505 | |
| TIDACQCHFDINLNF | 111 | P55160 | |
| ACARQHQEAFVCQIV | 396 | P78334 | |
| ANNRKHCIVDNGERC | 2686 | P98164 | |
| REFICNGVDNCHDNN | 2796 | P98164 | |
| DGHRCAGQQQDIRHC | 356 | P27918 | |
| NCDENAICTNTVQGH | 486 | Q92832 | |
| RVALCHLAGCQEQAA | 231 | Q8TEZ7 | |
| CISEDEGQNHQGQSC | 1371 | Q9BXP8 | |
| FANTCAECQQLIGHD | 36 | Q13643 | |
| CRIINLCENADQAHF | 1256 | Q9P2D3 | |
| EARNAAIANHCFTCA | 271 | Q9UBR1 | |
| AIANHCFTCAINRVG | 276 | Q9UBR1 | |
| RHDCILFANEFQQCC | 111 | Q8TF46 | |
| GHCLIINNVNFCRES | 161 | P55211 | |
| FHLINRFNNEDVCTC | 516 | P09172 | |
| SENDNVFCAQLQCFH | 226 | P98153 | |
| GNCNRGENDCRFAHP | 191 | Q9NR56 | |
| DCQHNTEGQHCDRCR | 361 | A4D0S4 | |
| QDNTDGAHCERCREN | 371 | P11047 | |
| FRCLNCNDNTDGIHC | 51 | Q13753 | |
| QGHAENQCVSCRAGT | 631 | Q9NQ36 | |
| AVCALGNNRVAHALC | 1671 | P21817 | |
| CAAGNCFSLQREHDI | 571 | P30260 | |
| CLNGGHCQNEINRFQ | 496 | P78504 | |
| CEEQNCSGGALNHFR | 36 | Q96FM1 | |
| GLDNAIDCHQGQCVL | 1096 | Q9H195 | |
| CNQIGSVHDRCNETG | 411 | Q96CW9 | |
| QDNRRHRGEFCEACQ | 181 | P59025 | |
| TLAHQNTRECQGECE | 126 | Q2I0M5 | |
| ENGCETHNQTARGFC | 556 | Q8N103 | |
| CFDNLQVCLEHTQAA | 4606 | Q8WXH0 | |
| CCNTEQAAEHFRNPQ | 986 | Q7Z3K3 | |
| DHVACVCEALQQGGN | 111 | Q9UIU6 | |
| CGQEIDAHSFVIRCN | 171 | Q92186 | |
| QLFGDVCFHCNRVIE | 246 | P48059 | |
| QNTCNNHFNAACGVR | 391 | Q4LDE5 | |
| AQAAQGHAFLGRCQE | 3311 | Q9NRC6 | |
| LGQACDFHQDCAQGE | 451 | Q9UM73 | |
| QAGNRHCFECAQRGV | 41 | O95081 | |
| CVGIFCEQQSNDTFH | 571 | P48995 | |
| EQGSHERLCRNAAVC | 736 | Q9ULJ3 | |
| RNHGLERLCESNDQC | 106 | Q8NEP9 | |
| NCEACGRAFIHDFQL | 261 | Q9UK11 | |
| ECGRAFNDNANLIRH | 221 | P17023 | |
| LQCLSEQRHQGFLCD | 11 | Q99592 | |
| CVHQGCFAAFTIQQN | 2116 | O60281 | |
| CSEFAICNHTGQVER | 1566 | Q8WWQ8 | |
| IDRCLQDNGQCHADA | 2171 | Q8WWQ8 | |
| QDNGQCHADAKCVDL | 2176 | Q8WWQ8 | |
| DATVLCHQLNCGNAV | 361 | Q4G0T1 | |
| DNFDCQNGAQCIVRI | 1126 | O94813 | |
| HCLFERNGAVSCQCN | 431 | P49746 | |
| IHAGEASCECQEIRN | 331 | Q96JL9 | |
| QIAHTGEQFLTCNQC | 536 | P21506 | |
| NGVADRCQIHFGDNR | 281 | Q53H54 | |
| FDINCNDHIICAGTE | 121 | Q96FK6 | |
| EQAAEFLFNQCICIH | 321 | Q9H9Y6 | |
| ERNHLGATLNECNQC | 136 | Q8N988 | |
| ECGRAFVQQCELTEH | 306 | Q6IV72 | |
| AEHINQDIFECRTCG | 1186 | O95071 | |
| EHGVCQLCNVNAQEL | 961 | Q5FWF4 | |
| RCAGEVSAAANNNIC | 211 | P16519 |